Ariel Miller
4Patents
4h-index
5Co-inventors
43Inventor score
Filing activity: Jun 6, 1995 → Aug 1, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6645504B1 | Bystander suppression of type I diabetes by oral administration of glucagon | Human Necessities | 50 | Expired |
| US5858980A | Peptide fragments of myelin basic protein | Human Necessities | 42 | Expired |
| US6036957A | Suppression of T-cell proliferation using peptide fragments of myelin basic protein | Human Necessities | 31 | Expired |
| US8945935B2 | Diagnosing, prognosing and monitoring multiple sclerosis | Emerging Cross-Sectional Technologies | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.